Clinical Trial Update: Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

View source ↗

Summary

Clinical trial evaluating adjuvant anti-PD-1 therapy in patients after resection of hepatocellular carcinoma. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Tongji Hospital | Conditions: HCC, Adjuvant Therapy | Status: NOT_YET_RECRUITING